Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

New Larger Volume Extraction System Increases Productivity and Sensitivity

By BiotechDaily International staff writers
Posted on 30 Jun 2014
ISOLUTE SLE+ One Milliliter Supported Liquid Extraction
One Milliliter Supported Liquid Extraction (Photo courtesy of BIOTAGE AB )
Biotechnology and other life science researchers now have available an extraction system for larger volumes that prepares samples of up to one milliliter for LC-MS/MS (liquid chromatography-mass spectroscopy) or GC-MS (gas chromatography-mass spectroscopy) analysis.

The Biotage (Uppsala, Sweden) ISOLUTE SLE+ One Milliliter Supported Liquid Extraction 48-well plate system enables the extraction of larger sample volumes (one milliliter total load volume) than is presently possible in the standard microplate format.

The new format tubes are packed with ISOLUTE SLE+ material, with each well containing sufficient ISOLUTE SLE+ material to efficiently extract one milliliter of aqueous sample. This is an alternative to the existing 96-well formats, which have a maximum capacity of 400 microliters. Larger sample volumes enable the researcher to generate higher sensitivity, higher throughput, and lower detection limits.

The ISOLUTE SLE+ plate is arranged in a six by eight array; with 48 samples being processed per plate. A new compatible 48-well collection plate is also available with a five milliliter capacity so that the entire elution solvent volume can be collected with no need to swap collection vessels.

The plates can be processed using microplate compatible positive pressure manifolds such as the Biotage Pressure+ 96, vacuum manifolds such as the Biotage VacMaster 96, and most automated liquid handling systems.

ISOLUTE SLE+ plates are ideal for the extraction of small molecule drugs, metabolites, and endogenous biomarkers from biological fluid samples prior to analytical techniques such as LC-MS/MS and GC-MS.

Related Links:

Biotage 




Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to BiotechDaily.com and get complete access to news and events that shape the world of biotechnology.
Free digital version edition of Bio Research International sent by email on regular basis
Free print version of Bio Research International magazine
(available only outside USA and Canada).
Free and unlimited access to back issues of Bio Research International in digital format
Free Bio Research International Newsletter sent every 2 weeks containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!


Click here to Register

Sign in: Registered website members
Username: Password:
Forgot username/password? Click here!
Sign in: Registered magazine subscribers
Subcode: Last Name:
What is SUBCODE?


comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: The new peptide offers a triple hormone effect in a single-cell molecule (Photo courtesy of Indiana University).

Tripeptide Drug Effectively Controls Metabolic Syndrome in Rodent Model

Promising results in reducing obesity and normalizing glucose metabolism obtained with a synthetic dipeptide drug have been enhanced by the addition of a molecule of a third hormone, glucagon.... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.